Articles

Results 1 to 5 of 179
Most popular |Most recent


China: Life sciences deals flourishing, but it’s largely a domestic story

China - July 8 2020 Like the rest of the world, China’s M&A activity has cooled as a direct result of the COVID-19 pandemic. Outbound deal volume in the second quarter...

Hong Kong opens the door to insurancelinked securities business

Hong Kong - July 7 2020 With the sharp rise in the number of natural and other large-scale catastrophic events in recent years and the challenges posed by climate change, the...

Sherry Xiao.

COVID-19: Daily Report for Life Sciences and Health Care Companies

USA - July 5 2020 The Daily Report is a compilation of COVID-19 (coronavirus) news briefs from around the world to help life sciences and health care companies stay...

Hein van den Bos, Karl Pörnbacher, Erkang Ai, Kent Phillips, Samaa Haridi, May Lyn Yuen, Cate Stetson, Ivan Zapien, Christine Zimmerman, Aaron Armstrong, Timothy Hill.

Are antitrust disputes arbitrable? The Supreme People's Court's view

China - July 1 2020 Including an arbitration clause is commonplace in China-related contracts, especially between Chinese and non-Chinese parties. Foreign companies...

James Kwan, Suyu Yuan.

Hong Kong Corporate Insights June 2020

Hong Kong - June 30 2020 On 18 June 2020 the HKEx announced plans To launch the HKEX Sustainable and Green Exchange (STAGE), a new information Platform which will act as a...

Sammy Li, Stephanie Tang, Laurence Davidson, Nelson Tang, Mark Parsons.